Feed aggregator

U.S. Food and Drug Administration accepts for Priority Review Bristol-Myers Squibb's application for Opdivo (nivolumab) plus Yervoy (ipilimumab) in first-line non-small cell lung cancer

World Pharma News - Fri, 01/17/2020 - 11:00
Bristol-Myers Squibb Company (NYSE: BMY) announced the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the first-line treatment of patients with metastatic or recurrent non-small cell lung cancer (NSCLC) with no EGFR or ALK genomic tumor aberrations.

J.P. Morgan Day 4: Moderna, Berkeley Lights, Sanofi, Pfizer and More

Biospace news - Fri, 01/17/2020 - 02:00
As the J.P. Morgan Healthcare Conference winds down for 2020, one of the big topics was the general lack of big deals. Still, there were some general trends and for today, some news.

Who are the 10 Most Innovative Biopharma Companies?

Biospace news - Fri, 01/17/2020 - 02:00
Here’s a look at the top 10 companies noted in the BioSpace Ideal Employer 2019 survey for being the most innovative and what they’ve been up to recently.

Novo Nordisk's Ozempic Wins Approval for Reducing Cardiovascular Events in Diabetes Patients

Biospace news - Fri, 01/17/2020 - 02:00
For patients with diabetes, the new indication could become a key for survival as there is a well-established link between cardiovascular disease and type 2 diabetes.

BioSpace Movers & Shakers, Jan. 17

Biospace news - Fri, 01/17/2020 - 02:00
Pharma companies add new members to executive ranks and boards of directors.

Research Roundup: Aging Along Certain Biological Pathways and More

Biospace news - Fri, 01/17/2020 - 02:00
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Eli Lilly Plans Spending Spree for 2020

Biospace news - Fri, 01/17/2020 - 02:00
Eli Lilly’s senior vice president and chief financial officer Josh Smiley announced plans for the company to spend from $1 billion to $5 billion each quarter this year as it plans to bolster its pipeline.

FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug

Biospace news - Fri, 01/17/2020 - 02:00
Posimir is a non-opioid being developed for post-surgical pain. It is designed to be injected into the surgical site, where it delivers bupivacaine for up to three days post-surgery.

BioNTech Acquires Neon Therapeutics to Bolster Immuno-Oncology Pipeline

Biospace news - Fri, 01/17/2020 - 02:00
“This acquisition fits with our strategy to expand our capabilities and build our presence in the U.S. and further strengthens our immunotherapy pipeline,” said Ugur Sahin, co-founder and chief executive officer of BioNTech.

Judge to Sentence Former Congressman in Insider Trading Case

Biospace news - Fri, 01/17/2020 - 02:00
Collins, a former member of the Innate Immunotherapeutics Board of Directors, was indicted in 2018 and resigned his seat last year.

What’s Wrong With Your Job Hunt? Diagnosing an Unproductive Search

Biospace news - Fri, 01/17/2020 - 02:00
Why can’t you land a job? If you’ve been searching for a few months, you may be asking yourself that question.

B cells linked to effective cancer immunotherapy

World Pharma News - Thu, 01/16/2020 - 13:00
Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumours contained specific clusters of B cells, according to new research from Lund University in Sweden. The study is published in Nature.

Edible 'security tag' to protect drugs from counterfeit

World Pharma News - Thu, 01/16/2020 - 11:00
Manufacturing prescription drugs with distinct markings, colors, shapes or packaging isn't enough to protect them from counterfeiting, U.S. Drug Enforcement Administration reports have shown. Purdue University researchers are aiming to stump counterfeiters with an edible "security tag" embedded into medicine.

J.P. Morgan Trends: Digital Health Confusion, Tech, Drug Prices and Diversity

Biospace news - Thu, 01/16/2020 - 02:00
As the J.P. Morgan Healthcare Conference enters its final day for 2020, a few topics have risen to the top.

Former Insys Executive Found Guilty for Opioid Marketing Schemes Sentenced to 33 Months

Biospace news - Thu, 01/16/2020 - 02:00
The first of the Insys Therapeutics executives found guilty of violating the Racketeer Influenced and Corrupt Organizations Act in May 2019 has been sentenced.

BioSpace Global Roundup, Jan. 16

Biospace news - Thu, 01/16/2020 - 02:00
Companies from across the globe provide updates to their business and pipeline.

In 13th Global Deal, WuXi Bio Buys Germany-based Manufacturing Plant from Bayer

Biospace news - Thu, 01/16/2020 - 02:00
“We are excited to sign this acquisition agreement with Bayer, allowing us to have quick access to high-quality drug product manufacturing capacities and capabilities,” said Chris Chen, chief executive officer of WuXi Biologics.

Possible IPO Timeline for GSK and Pfizer Healthcare Company

Biospace news - Thu, 01/16/2020 - 02:00
The two companies joined their consumer health businesses in order to give the parent companies more maneuverability to focus on the pharmaceuticals.

Moderna Partners with AWS to Explore the 'Software of Life'

Biospace news - Thu, 01/16/2020 - 02:00
The company, which has secured enormous investments over the past few years, is inching closer to being a commercial company in developing personalized therapies for a wide range of diseases, including cancer.

Preparing for Behavioral Interviews with the STAR Method

Biospace news - Thu, 01/16/2020 - 02:00
When using the STAR Method, be sure to discuss the who, what, where, when and how of an experience.